Logo

Moffitt Cancer Center

Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine

The acquisition brings Interpares' genetic sequencing test, OncoGuardian, into Clarified's portfolio of precision medicine products.

Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression

The group aims to determine the feasibility of TROLL-2 and TROLL-3 as diagnostic biomarkers for the prediction of treatment efficacy and prognosis in breast cancer.

Blood-Based Genetic Risk Score Shows Promise for Prostate Cancer Drug Response, Survival Prediction
Premium

The team envisions developing an assay to guide targeted treatment for metastatic castration-resistant prostate cancer patients.   

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests
Premium

Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.

New Coalition, Stakeholder Groups Push Back Against FDA 'Backdoor' Attempts to Regulate PGx Tests
Premium

While some groups have communicated their concerns directly to the agency, stakeholders have also formed a new coalition to publicly take issue with FDA's actions.

Apr 10, 2019

FDA Warning Letter to Inova Raises Questions About Agency Overreach Into Practice of Medicine
Premium

Apr 26, 2018

ABRF Speakers Outline Disaster Prep for Core Facilities

Sep 29, 2017

With M2Gen Investment, Hearst Seeks to Marry Genomic Cancer Data With Clinical Records
Premium

Sep 20, 2017

Hearst Invests $75M in M2Gen

Mar 27, 2017

International Consortium Links Dozen Loci to Ovarian Cancer Susceptibility

Mar 10, 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point
Premium

Dec 21, 2016

Moffitt Cancer Center Develops Personalized Genomics Approach to Radiation Therapy

Sep 12, 2016

HudsonAlpha to Provide Sequencing Services for ORIEN Cancer Initiative

Jun 15, 2016

Targeted Colorectal Cancer Sequencing Leads to Potential Prognostic Role for APC Gene

Jun 5, 2016

Epigenetic Differences May Explain Lack of Response to Metastatic Melanoma Immunotherapy

Sep 8, 2015

Signal Genetics, Moffitt Cancer Center Partner on Multiple Myeloma Research

Aug 28, 2015

Moffitt Team Uses Nanostring Tech to ID MiRNA Signature for Early Pancreatic Cancer Detection
Premium

Aug 11, 2015

Researchers Continue Building Evidence Around Precision Radiation Molecular Tool
Premium

Aug 4, 2015

Institutional 'Diversity' May Impact Patient Participation in PGx Research, Study Finds
Premium

May 11, 2015

Moffitt Advancing Preemptive PGx Testing Effort to Optimize Treatment for Patients Receiving Chemo
Premium

Feb 23, 2015

New Centers Join ORIEN to Uncover Cancer Molecular Data

Jan 15, 2015

Proximity Ligation Assays Show Potential to Detect Altered EGFR Signaling, Predict Drug Response
Premium

Sep 23, 2014

Forma, Moffitt Collaborate on Epigenetics Research

Sep 17, 2014

Research Shows Promise of Genomic Testing to Predict Whether Cancer Patients Benefit from Radiation
Premium

Sep 2, 2014

Rosetta Genomics, Moffitt Cancer Center to Collaborate on microRNA Cancer Diagnostics

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.